Down syndrome (T21): low AFP, low estriol, HIGH beta-hCG, HIGH inhibin A. Edwards (T18): low AFP, low estriol, low hCG, normal inhibin A. Open NTD: HIGH maternal serum AFP.
Screen 50g 1-hr GCT (>=140) -> confirm 100g 3-hr OGTT (>=2 of: Fasting >=95, 1h >=180, 2h >=155, 3h >=140). Rx: Diet/exercise 1st -> Insulin (#1 pharmacotherapy).
Intrapartum IV Penicillin G if positive 36-37w rectovaginal culture, GBS bacteriuria ANY time in current pregnancy, prior infant with GBS sepsis, or unknown status + fever/<37w/ROM >=18h.
Ampulla of fallopian tube (#1 site). Discriminatory zone: beta-hCG >=1,500-2,000 mIU/mL with empty uterus on TVUS. Rx: Methotrexate if stable/unruptured; Laparoscopic salpingectomy if ruptured.
Complete (46,XX paternal uniparental): snowstorm US, no fetal parts, hCG >100,000, hyperemesis/preeclampsia <20w, 15-20% choriocarcinoma risk. Rx: Suction curettage + serial weekly beta-hCG.
HTN in pregnancy: Labetalol, Nifedipine, Methyldopa (STOP ACEi/ARBs!). Anticoagulation: Heparin/LMWH (STOP Warfarin!). Hyperthyroidism: PTU in 1st trimester -> Methimazole in 2nd/3rd.
Active phase starts at >=6 cm cervical dilation. Arrest = >=6 cm with ruptured membranes and NO cervical change for >=4 hours of adequate contractions (>=200 MVUs) or >=6 hours of inadequate contractions -> C-section.
Polymicrobial ascending uterine infection 2-3 days after Cesarean delivery (fever, uterine fundal tenderness, foul lochia). Rx: IV Clindamycin + Gentamicin (add Ampicillin if no response).
Gestational Diabetes & Rh Alloimmunization Protocols
Routine prenatal screening at 24 to 28 weeks gestation includes two milestone protocols: (1) Universal screening for Gestational Diabetes Mellitus (GDM, driven by placental secretion of human placental lactogen [hPL], progesterone, cortisol, and growth hormone, which induce maternal insulin resistance to ensure transplacental glucose delivery to the fetus) and (2) Administration of Anti-D Immune Globulin (RhoGAM) at 28 weeks to unsensitized RhD-negative mothers to prevent maternal alloimmunization and Hemolytic Disease of the Fetus and Newborn (HDFN).
| Clinical Entity | Screening Timing & Diagnostic Criteria | Fetal & Maternal Risks | Evidence-Based Management |
|---|---|---|---|
| Gestational Diabetes Mellitus (GDM) | Screen at 24–28 weeks: 50 g 1-hr screen (≥ 140 mg/dL abnormal); Confirm: 100 g 3-hr OGTT (≥ 2 abnormal: Fasting ≥ 95, 1-hr ≥ 180, 2-hr ≥ 155, 3-hr ≥ 140) | Fetal macrosomia (> 4,500 g), shoulder dystocia, neonatal hypoglycemia, polycythemia, hyperbilirubinemia, respiratory distress syndrome | First-line: Diabetic nutritional counseling and exercise; Pharmacotherapy: Insulin (first-line agent; does not cross placenta); Metformin or Glyburide if insulin declined |
| Rh (D) Alloimmunization | Initial prenatal visit: Maternal ABO/Rh type and antibody screen; Unsensitized Rh-negative: Anti-D antibody titer negative | Anti-D IgG crosses placenta → fetal hemolysis → severe anemia → high-output heart failure → Erythroblastosis fetalis / Hydrops fetalis | Anti-D Immune Globulin (RhoGAM 300 μg): 1. At 28 weeks gestation, 2. Within 72 hours of delivery of Rh+ infant, 3. Following any bleeding event, amniocentesis, or trauma; Kleihauer-Betke test guides postpartum dose |
Gestational Diabetes Mellitus: 24–28w Two-Step Screening (50g -> 100g Carpenter-Coustan), Fasting/Postprandial Targets & Neonatal Macrosomia/Hypoglycemia
In the United States, universal screening for Gestational Diabetes Mellitus (GDM) is performed at 24 to 28 weeks gestation (earlier at the first prenatal visit if the mother has obesity/history of prior GDM) using the Two-Step Approach: Step 1 is a non-fasting 1-hour 50-gram Oral Glucose Challenge Test (GLT); if the 1-hour venous glucose is <130–140 mg/dL, GDM is ruled out; if the 1-hour glucose is ≥130–140 mg/dL, proceed to Step 2: the Fasting 3-Hour 100-gram Oral Glucose Tolerance Test (OGTT). GDM is diagnosed if AT LEAST TWO (≥2) of the four Carpenter-Coustan thresholds are met or exceeded (mnemonic 95 – 180 – 155 – 140): Fasting ≥95 mg/dL, 1-Hour ≥180 mg/dL, 2-Hour ≥155 mg/dL, and 3-Hour ≥140 mg/dL (note: if the 1-hour 50g screen is extremely elevated ≥200 mg/dL, GDM can be diagnosed directly without a 3-hour test!). Understand the maternal-fetal pathophysiology (Pedersen Hypothesis): maternal glucose freely crosses the placenta via facilitated diffusion (GLUT-1), whereas maternal insulin CANNOT cross the placenta; maternal hyperglycemia forces the fetal pancreas to secrete excessive fetal insulin (which acts as a potent fetal growth factor), causing Fetal Macrosomia (>4,000–4,500 g), Shoulder Dystocia (brachial plexus Erb-Duchenne C5–C6 palsy), Polyhydramnios (fetal osmotic diuresis), Delayed Fetal Lung Maturation (fetal hyperinsulinemia antagonizes cortisol-stimulated surfactant synthesis → Neonatal Respiratory Distress Syndrome!), and Neonatal Hypoglycemia, Hypocalcemia, and Polycythemia immediately after umbilical cord clamping (note: unlike pregestational Type 1/2 diabetes—which causes 1st-trimester organogenesis defects like caudal regression/sacral agenesis, neural tube defects, and transposition of the great vessels—true GDM develops in the late 2nd trimester after organogenesis is complete, so GDM does NOT increase congenital anomalies!). First-line GDM treatment is Medical Nutrition Therapy (diet) + 30 minutes of moderate postprandial exercise for 1–2 weeks targeting strict glycemic cutoffs: Fasting <95 mg/dL, 1-Hour Postprandial <140 mg/dL, and 2-Hour Postprandial <120 mg/dL; if targets are not met, First-Line Pharmacotherapy in Pregnancy is INSULIN (which does not cross the placenta; 4–12 weeks postpartum, perform a 75-gram 2-hour OGTT because 50% of GDM mothers develop Type 2 Diabetes!).
Rh(D) Alloimmunization: Indirect Coombs Screen, 28w & 72h RhoGAM, Kleihauer-Betke Rosette Dose & MCA Peak Systolic Velocity
At the first prenatal visit, every pregnant patient undergoes ABO and Rh(D) blood typing PLUS an Indirect Coombs Test (Antibody Screen). If an Rh(D)-negative mother carries an Rh(D)-positive fetus, fetomaternal hemorrhage exposes the mother to fetal D-antigen: the initial primary maternal immune response produces large pentameric IgM anti-D antibodies (which CANNOT cross the placenta), but subsequent exposure triggers class-switching to IgG anti-D antibodies, which freely cross the placenta via FcRn receptors to coat and destroy fetal red blood cells—causing Fetal Anemia, High-Output Cardiac Failure, Generalized Edema (≥2 fluid compartments: ascites, pleural/pericardial effusions, skin scalp edema = Immune Hydrops Fetalis), Extramedullary Hematopoiesis, and Kernicterus. Follow this exact 2-branch algorithm: Branch A — Unsensitized Rh-Negative Mother (Indirect Coombs Antibody Screen is NEGATIVE): administer prophylactic 300 μg IM Anti-D Immune Globulin (RhoGAM) routinely at 28 weeks gestation AND again within 72 hours after delivery of an Rh-positive infant—PLUS after any potential fetomaternal hemorrhage event (spontaneous/induced abortion, ectopic pregnancy, amniocentesis/CVS, placental abruption, abdominal trauma, or external cephalic version). After major placental trauma/abruption, perform a Rosette screen followed by a quantitative Kleihauer-Betke Acid Elution Test (fetal HbF resists acid elution and stains bright pink while maternal HbA ghosts are pale) to calculate total fetal whole blood volume in maternal circulation: each 300 μg vial of RhoGAM neutralizes 30 mL of fetal whole blood (or 15 mL of fetal RBCs)! Branch B — Already Sensitized Rh-Negative Mother (Indirect Coombs is POSITIVE for anti-D IgG): RhoGAM is completely useless once sensitization has occurred! Instead, serial maternal anti-D titers are followed until they reach the critical threshold (≥1:16 to 1:32), at which point the fetus is monitored non-invasively for moderate-to-severe anemia using Doppler Ultrasound of the Fetal Middle Cerebral Artery (MCA) Peak Systolic Velocity (PSV) (anemic blood has lower viscosity and higher cardiac output, accelerating MCA velocity to >1.5 Multiples of the Median [MoM] → treat with cordocentesis and intrauterine umbilical vein RBC transfusion!). Note that anti-Kell, anti-Duffy, and anti-Kidd IgG antibodies also cause severe HDFN, whereas anti-Lewis antibodies are benign IgM that cannot cross the placenta.
Preterm Labor Master Algorithm (< 37 Weeks)
Preterm Labor—defined as regular uterine contractions accompanied by progressive cervical dilation (≥2 cm) and/or effacement (≥80%) occurring between 20 0/7 and 36 6/7 weeks gestation—and Preterm Prelabor Rupture of Membranes (PPROM) are the leading causes of neonatal morbidity and mortality. Clinical management integrates gestational-age–specific Antenatal Corticosteroids (Betamethasone), short-term Tocolytics (48-hour steroid/transport window), Magnesium Sulfate for fetal neuroprotection (<32 weeks), and Group B Streptococcus intrapartum prophylaxis.
| Gestational Age | Mandatory Interventions | Tocolytic of Choice | Target Physiologic Outcome |
|---|---|---|---|
| < 32 Weeks Gestation | Betamethasone (IM × 2 doses 24 hrs apart) + Magnesium Sulfate (IV load then infusion) + Ampicillin/Penicillin (GBS prophylaxis) | Indomethacin (COX inhibitor; first-line < 32 wks; limit to 48 hours to prevent premature ductus arteriosus closure and oligohydramnios) | Lung maturity (surfactant), fetal cerebral palsy reduction (neuroprotection via MgSO4), GBS sepsis prevention |
| 32 to 34 Weeks Gestation | Betamethasone + GBS chemoprophylaxis | Nifedipine (oral calcium channel blocker; smooth muscle relaxation; watch maternal hypotension) | Accelerate pulmonary pneumocyte type II surfactant production |
| 34 to 36 6/7 Weeks (Late Preterm) | Betamethasone single course (if not previously given) + GBS prophylaxis if indicated | Tocolysis generally NOT recommended unless delivery delayed for maternal transfer | Reduce neonatal respiratory morbidity |
Gestational Age Tocolytic Selection (<32w Indomethacin vs. 32–34w Nifedipine), Contraindications & Betamethasone Surfactant Acceleration
When a patient presents with intact membranes and preterm labor prior to 34 0/7 weeks gestation, the goal of Short-Term Tocolysis (up to 48 hours) is NOT to prolong pregnancy indefinitely, but specifically to buy a 48-hour window for Antenatal Corticosteroids to accelerate fetal lung maturity and allow maternal transport to a tertiary NICU center. (1) Antenatal Corticosteroids (Betamethasone 12 mg IM q24h × 2 doses, or Dexamethasone 6 mg IM q12h × 4 doses) are indicated for all patients at risk of preterm delivery within 7 days between 24 0/7 and 33 6/7 weeks gestation (and late preterm 34 0/7–36 6/7w if no prior course): corticosteroids stimulate fetal Type II pneumocytes to synthesize lecithin (dipalmitoylphosphatidylcholine) surfactant, reducing Neonatal Respiratory Distress Syndrome (RDS), Intraventricular Hemorrhage (IVH), Necrotizing Enterocolitis (NEC), and perinatal death! (2) First-Line Tocolytic Selection by Gestational Age & Contraindications: Between 24 and 32 weeks gestation, first-line tocolytics are Indomethacin (NSAID inhibiting prostaglandin synthesis; STRICTLY CONTRAINDICATED AT ≥32 WEEKS GESTATION because it causes premature closure of the fetal Ductus Arteriosus and oligohydramnios by reducing fetal renal GFR, and contraindicated in maternal platelet/bleeding dysfunction, peptic ulcer disease, or renal insufficiency!) OR Nifedipine (dihydropyridine L-type Ca2+ channel blocker relaxing myometrial smooth muscle; First-Line between 32 and 34 weeks gestation; contraindicated in maternal hypotension [<90/50], preload-dependent cardiac lesions, or concomitant use with Magnesium Sulfate due to synergistic neuromuscular blockade!). Terbutaline (β2-adrenergic agonist increasing myometrial cAMP) is used acutely for tachysystole/tocolysis but is contraindicated in maternal tachycardia, cardiac arrhythmia, poorly controlled hyperthyroidism, or diabetes (causes maternal tachycardia, pulmonary edema, hyperglycemia, and hypokalemia). (3) Fetal Neuroprotection: If imminent preterm birth is anticipated at <32 0/7 weeks gestation, administer Intravenous Magnesium Sulfate, which stabilizes fetal cerebral vascular tone and reduces the incidence of Cerebral Palsy! Never administer tocolytics if intra-amniotic infection (chorioamnionitis), severe preeclampsia/eclampsia, placental abruption, non-reassuring fetal status, or intrauterine fetal demise is present!
PPROM Diagnosis (Pooling, Nitrazine, Ferning) & Management (<34w Latency Antibiotics vs. >=34w Delivery) & GBS Prophylaxis Rules
Prelabor Rupture of Membranes (PROM) is rupture of the chorioamniotic membranes prior to the onset of labor (termed PPROM when occurring at <37 0/7 weeks gestation). Diagnosis is made on sterile speculum examination (avoid digital cervical exams in PPROM, as digital exams introduce vaginal flora and shorten latency to chorioamnionitis!) by observing (1) Direct pooling of amniotic fluid in the posterior vaginal fornix or fluid leaking from the cervical os on cough/Valsalva, (2) Nitrazine paper turning dark BLUE (normal vaginal pH is acidic [3.8–4.5], whereas amniotic fluid is alkaline [pH 7.1–7.3]; false-positives occur with blood, semen, or Bacterial Vaginosis), and (3) 'Ferning' (arborization pattern) of dried amniotic fluid under light microscopy due to sodium chloride crystallization under estrogen influence (if equivocal, check ultrasound amniotic fluid index or PAMG-1 [AmniSure] assay). Management of PPROM depends strictly on gestational age and infection status: if Chorioamnionitis (Triple I: maternal fever ≥38.0°C plus fetal tachycardia, maternal leukocytosis, uterine fundal tenderness, or purulent amniotic fluid), placental abruption, or non-reassuring fetal testing is present at any gestational age, proceed to Immediate Delivery + IV Ampicillin and Gentamicin! If uninfected: at ≥34 0/7 weeks (to 37w), proceed to Delivery (induction of labor with IV oxytocin); at 24 0/7 to 33 6/7 weeks, admit for Expectant Management with Betamethasone + a 7-day course of Latency Antibiotics (IV Ampicillin + Erythromycin/Azithromycin for 48 hours followed by Oral Amoxicillin + Erythromycin/Azithromycin for 5 days—which prolongs pregnancy latency and reduces neonatal chorioamnionitis/sepsis; NEVER use Amoxicillin-Clavulanate [Augmentin] in PPROM because it increases neonatal Necrotizing Enterocolitis [NEC]!). Finally, memorize the Group B Streptococcus (S. agalactiae) Intrapartum IV Penicillin G Prophylaxis Indications: screen all pregnant women with a rectovaginal culture at 36 0/7 to 37 6/7 weeks, and give intrapartum IV Penicillin G (or Ampicillin) for positive culture, unknown culture status with preterm labor (<37w), rupture of membranes ≥18 hours, or intrapartum fever ≥38.0°C—and give automatic prophylaxis WITHOUT needing a culture if the mother had GBS bacteriuria at any concentration during the current pregnancy OR a prior infant with invasive GBS disease!
Routine Prenatal Care Timeline, Aneuploidy Quad Screen & GBS Prophylaxis
Standardized prenatal care follows a gestational age-based screening calendar designed to detect chromosomal aneuploidies, structural neural tube defects, gestational diabetes, Rh alloimmunization, and vertical infectious pathogens before fetal or maternal morbidity occurs. Obstetric dating is anchored to Naegele's rule (First day of Last Menstrual Period [LMP] − 3 months + 7 days + 1 year), though first-trimester crown-rump length (CRL) on transvaginal ultrasound is the most accurate method to establish or revise Estimated Gestational Age (EGA). Visit frequency follows a strict schedule: every 4 weeks until 28 weeks, every 2 weeks from 28 to 36 weeks, and weekly from 36 weeks until delivery.
| Gestational Age Window | Mandatory Screening Tests & Interventions | Diagnostic Interpretation & Pathologic Patterns | Definitive Confirmatory Test / Clinical Action |
|---|---|---|---|
| Initial Prenatal Visit (6–10 weeks) | CBC, Blood type & Rh(D) + Antibody screen, Rubella/Varicella immunity, HBsAg, HIV, Syphilis (RPR), Chlamydia/Gonorrhea NAAT, Urinalysis + Urine culture, Pap smear (if due) | Asymptomatic Bacteriuria (≥105 CFU/mL): Progresses to acute pyelonephritis in 20–40% of pregnant patients due to progesterone-induced ureteral smooth muscle relaxation | Treat asymptomatic bacteriuria with Nitrofurantoin, Amoxicillin-Clavulanate, or Cephalexin for 5–7 days + test-of-cure culture (AVOID fluoroquinolones and tetracyclines!; avoid TMP-SMX in 1st trimester) |
| First Trimester (10–13 weeks) | Cell-free fetal DNA (cfDNA / NIPT) (≥10w); First-trimester combined screen: Nuchal Translucency (NT) US + PAPP-A + free β-hCG | Down Syndrome (Trisomy 21) in 1st Trimester: Increased Nuchal Translucency, LOW PAPP-A, and HIGH β-hCG (absent nasal bone) | Screen-positive cfDNA or 1st-trimester screen must be confirmed via invasive karyotyping: Chorionic Villus Sampling (CVS) at 10–13 weeks (risk: transverse digital limb defects if <9w) |
| Second Trimester (15–22 weeks) | 15–20w Maternal Serum Quad Screen: AFP, Unconjugated Estriol (uE3), β-hCG, Inhibin A. 18–22w: Comprehensive fetal anatomy ultrasound | Trisomy 21 (Down): ↓ AFP, ↓ Estriol, ↑ β-hCG, ↑ Inhibin A. Trisomy 18 (Edwards): ↓ AFP, ↓ Estriol, ↓ β-hCG, Normal/↓ Inhibin A. Open Neural Tube / Ventral Wall Defect: ↑↑ Maternal Serum AFP | Confirm aneuploidy via Amniocentesis at 15–20 weeks. High AFP → first perform ultrasound to verify gestational dating (wrong dates is #1 cause of abnormal AFP!) and inspect spine/abdominal wall |
| Third Trimester Entry (24–28 weeks) | 1) 1-hour 50g Oral Glucose Challenge Test (GCT) 2) Repeat CBC (physiologic dilutional anemia Hb <11 g/dL) & Antibody screen 3) 28w RhoGAM (300 μg IM) if Rh(D)-negative and Indirect Coombs negative | If 1-hr 50g GCT ≥140 mg/dL → perform confirmatory 3-hour 100g OGTT (Carpenter-Coustan ≥2 abnormal values: Fasting ≥95, 1h ≥180, 2h ≥155, 3h ≥140 mg/dL) | GDM Goals: Fasting <95, 1h postprandial <140, 2h <120 mg/dL. Rx: Diet/exercise → Insulin (1st line; does not cross placenta). Repeat RhoGAM within 72h postpartum if infant is Rh(D)+ (use Kleihauer-Betke to dose fetomaternal hemorrhage) |
| Late Third Trimester (36–37 weeks) | Group B Streptococcus (GBS / S. agalactiae) lower vaginal-rectal swab culture; assess fetal Leopold presentation (ECV at 37w if breech) | GBS colonizes maternal GI/vaginal tract in 20–30%; vertical intrapartum transmission causes early-onset neonatal sepsis, pneumonia, and meningitis | Administer Intrapartum IV Penicillin G (≥4 hours prior to delivery) if positive culture, prior infant with GBS sepsis, or GBS bacteriuria in current pregnancy |
Quad Screen Memorization Logic & Neural Tube Defect Workup
To master the second-trimester Quad Screen (15–20 weeks), remember that Trisomy 21 (Down syndrome) elevates the two placental glycoproteins that contain alpha/beta subunits (HIGH β-hCG and HIGH Inhibin A) while depressing fetal hepatic/adrenal synthesis (LOW AFP and LOW unconjugated Estriol). In Trisomy 18 (Edwards syndrome: clenched fists with overlapping fingers, rocker-bottom feet, micrognathia, prominent occiput, VSD), ALL markers are LOW (↓ AFP, ↓ Estriol, ↓ β-hCG) with normal/low Inhibin A. Conversely, an Elevated Maternal Serum AFP indicates leakage of fetal serum protein directly into amniotic fluid across an uncovered lesion: anencephaly, open spina bifida (myelomeningocele), gastroschisis, omphalocele, or multiple gestation (note: the most common overall cause of an abnormal AFP or Quad screen is inaccurate gestational dating, so always verify dating by ultrasound first!).
Group B Streptococcus (GBS) Intrapartum Prophylaxis Exceptions
Universal rectovaginal culture for Streptococcus agalactiae is performed at 36 0/7 to 37 6/7 weeks. Two patient groups automatically receive intrapartum IV Penicillin G (or Ampicillin) without needing a 36-week swab: (1) women with GBS bacteriuria (at any colony count, symptomatic or asymptomatic) detected at any point during the current pregnancy, and (2) women with a prior infant affected by early-onset invasive GBS disease. Conversely, women undergoing a planned Cesarean delivery before the onset of labor with intact amniotic membranes do NOT require GBS antibiotic prophylaxis, even if their 36-week GBS culture is positive.
Folate Supplementation for Neural Tube Defect Prevention
Because closure of the anterior and posterior neuropores completes by day 28 post-conception (6 weeks gestational age), all patients capable of becoming pregnant require daily folic acid supplementation starting at least 1 month prior to conception through the first trimester: 0.4 mg (400 μg) daily for standard-risk women, and 4 mg (4,000 μg) daily for high-risk women (prior child with a neural tube defect, maternal pregestational diabetes, or maternal exposure to folate-antagonist anticonvulsants such as valproate or carbamazepine).
First-Trimester Bleeding Differential: Ectopic Pregnancy, Spontaneous Abortion & Molar Disease
First-trimester vaginal bleeding and pelvic pain require immediate integration of hemodynamic vital signs, quantitative serum β-hCG, Rh(D) blood type, speculum exam of the internal cervical os (closed vs. dilated), and transvaginal ultrasound (TVUS). In a normal intrauterine pregnancy, quantitative serum β-hCG doubles approximately every 48 hours, and once serum β-hCG reaches the discriminatory zone (1,500–2,000 mIU/mL), a gestational sac must be visible inside the uterine cavity on TVUS. Absence of an intrauterine gestational sac when β-hCG exceeds the discriminatory zone—or a suboptimal (<35–50%) rise over 48 hours—establishes an Ectopic Pregnancy until proven otherwise.
| First-Trimester Condition | Pathophysiology / Karyotype | Cervical Os & Clinical Presentation | Ultrasound / β-hCG & Definitive Management |
|---|---|---|---|
| Ectopic Pregnancy | >95% implant in the Ampulla of the Fallopian tube. Risk factors: Prior PID (C. trachomatis), prior ectopic, tubal surgery/ligation, IUD in place, smoking | Unruptured: Amenorrhea (6–8w), unilateral adnexal pain, scant vaginal spotting, cervical motion tenderness. Ruptured: Sudden severe peritoneal abdomen, shoulder pain (diaphragmatic blood), hypotension/tachycardia (hemorrhagic shock) | TVUS: Empty uterus with β-hCG >1,500–2,000 + adnexal ring/free fluid. Ruptured / Unstable: Emergent Laparoscopic Salpingectomy. Unruptured + Stable: IM Methotrexate (if β-hCG <5,000, mass <3.5 cm, NO fetal cardiac activity) |
| Threatened vs. Inevitable Abortion | Chromosomal aneuploidy (trisomy 16) accounts for >50% of first-trimester spontaneous losses | Threatened: Vaginal bleeding with CLOSED cervical os and viable fetal cardiac activity. Inevitable: Vaginal bleeding + crampy pain with DILATED cervical os and intact/rupturing membranes (no tissue passed yet) | Threatened: Pelvic rest + reassurance (+ RhoGAM if Rh-negative). Inevitable / Incomplete / Missed: Expectant vs medical (Misoprostol ± Mifepristone) vs surgical (Suction dilation & curettage [D&C] if heavy bleeding or septic) |
| Incomplete vs. Complete vs. Missed Abortion | Subclassified by passage of products of conception (POC) and cervical os status before 20 weeks gestation | Incomplete: DILATED os + partial passage of POC (retained placental tissue on US). Complete: CLOSED os after complete passage of all POC (empty uterus, thin endometrial stripe). Missed: CLOSED os + fetal demise (absent heartbeat) retained in uterus without bleeding | Septic Abortion: Fever, leukocytosis, purulent cervical discharge, tender boggy uterus after incomplete/unsterile abortion → Immediate IV broad-spectrum antibiotics (Gentamicin + Clindamycin ± Ampicillin) + Urgent Suction Curettage |
| Complete Hydatidiform Mole | 46,XX (90%) or 46,XY completely paternal DNA (enucleated empty ovum fertilized by one sperm that duplicates, or two sperm); p57-negative on IHC | Painless 1st-trimester bleeding, uterus size > dates, passage of grape-like hydropic villi, β-hCG >>100,000 mIU/mL causing hyperemesis gravidarum, bilateral theca-lutein ovarian cysts, hyperthyroidism (α-subunit homology with TSH), and preeclampsia <20 weeks | TVUS: Diffuse 'snowstorm' echogenic mass with NO fetal parts and NO amniotic fluid; 15–20% risk of invasive mole / choriocarcinoma. Rx: Suction Curettage + Weekly serial β-hCG until undetectable (+ OCP contraception for 6 months!) |
| Partial Hydatidiform Mole | Triploid (69,XXX, 69,XXY, or 69,XYY) containing both maternal and paternal DNA (normal haploid ovum fertilized by two sperm); p57-positive | Vaginal bleeding with uterus size normal or small for dates; lower β-hCG elevation than complete mole; rare theca-lutein cysts or preeclampsia | TVUS: Focal hydropic villi ('Swiss-cheese' placenta) WITH fetal parts, amniotic fluid, and fetal cardiac activity present; <5% risk of gestational trophoblastic neoplasia. Rx: Suction curettage + serial β-hCG monitoring |
Ectopic Pregnancy Ultrasound & Methotrexate Eligibility Criteria
Transvaginal ultrasound (TVUS) of a tubal Ectopic Pregnancy classically demonstrates an empty endometrial cavity (or pseudogestational sac) paired with a complex extraovarian adnexal mass ('tubal ring sign') and echogenic free fluid in the rectouterine pouch of Douglas. Medical management with intramuscular Methotrexate (a dihydrofolate reductase inhibitor that halts rapidly dividing trophoblasts) is indicated ONLY when the patient is hemodynamically stable without peritoneal signs, serum β-hCG is <5,000 mIU/mL, adnexal mass is <3.5–4.0 cm, fetal cardiac activity is absent, and there are no contraindications (no renal/hepatic disease, peptic ulcer, immunodeficiency, or breastfeeding). Check β-hCG on days 4 and 7 post-methotrexate, expecting a ≥15% decline between day 4 and day 7.
Transvaginal POCUS Reference for Adnexal Ectopic Gestation
Point-of-care pelvic ultrasound in a patient with first-trimester pain and a positive β-hCG must evaluate both the endometrial stripe and the adnexa. Identification of an extrauterine gestational sac or complex adnexal mass alongside free pelvic fluid in Morison pouch or the cul-de-sac confirms ruptured ectopic pregnancy and mandates immediate surgical intervention.
Post-Molar Surveillance & Gestational Choriocarcinoma
Following uterine suction evacuation of a Complete or Partial Hydatidiform Mole, patients must have weekly quantitative serum β-hCG levels measured until undetectable for 3 consecutive weeks, then monthly for 6 months—while taking reliable oral contraception so a new normal pregnancy does not mask a rising tumor marker. If β-hCG plateaus over 3 weeks or rises over 2 weeks, diagnose Gestational Trophoblastic Neoplasia (Invasive Mole or Choriocarcinoma). Gestational choriocarcinoma (malignant syncytiotrophoblasts and cytotrophoblasts without chorionic villi) hematogenously metastasizes early to the lungs ('cannonball' nodules, hemoptysis, dyspnea), vagina, and brain, but is highly curable (~95–100%) with single-agent Methotrexate or Dactinomycin chemotherapy.
Teratogens in Pregnancy Master Reference & Safe Pharmacologic Alternatives
Fetal vulnerability to teratogenic medications and congenital infections depends critically on the embryonic timing of exposure. Exposure during the pre-implantation / all-or-none period (Weeks 0–2 post-fertilization) typically results in either spontaneous embryonic demise or complete repair without congenital malformations. The embryonic period of organogenesis (Weeks 3–8 post-fertilization / Weeks 5–10 LMP) is the window of maximum teratogenic susceptibility, during which interference with neural crest migration, folate metabolism, or limb-bud angiogenesis produces major structural defects. Exposure during the fetal period (Weeks 9–40) disrupts tissue growth and physiological maturation (e.g., ACE inhibitor fetal renal tubular dysgenesis or NSAID premature closure of the ductus arteriosus).
| Clinical Condition / Drug Class | Contraindicated Teratogen | Classic Fetal Teratogenic Syndrome / Defect | Safe First-Line Alternative in Pregnancy |
|---|---|---|---|
| Chronic / Gestational Hypertension | ACE Inhibitors (Lisinopril) & ARBs (Losartan) | Fetal renal tubular dysgenesis → anuria → Oligohydramnios → Potter Sequence (pulmonary hypoplasia, limb contractures, flat facies) + calvarial hypoplasia | Labetalol, Nifedipine (extended-release), or Methyldopa (Hydralazine IV for acute hypertensive crisis) |
| Anticoagulation (DVT / PE / Antiphospholipid) | Warfarin (crosses placenta; inhibits vitamin K epoxide reductase in fetal bone/cartilage) | Fetal Warfarin Syndrome: Nasal hypoplasia (depressed nasal bridge), stippled epiphyses (chondrodysplasia punctata), optic atrophy, fetal CNS hemorrhage | Low-Molecular-Weight Heparin (Enoxaparin) or Unfractionated Heparin (large negatively charged molecules that DO NOT cross the placenta!) |
| Epilepsy / Bipolar Disorder | Valproic Acid, Carbamazepine, Phenytoin, Lithium | Valproate/Carbamazepine: Neural tube defects (spina bifida / meningomyelocele). Phenytoin: Fetal hydantoin syndrome (cleft palate, nail/digital hypoplasia, microcephaly). Lithium: Ebstein anomaly (apical displacement of tricuspid valve, atrialized RV) | Epilepsy: Lamotrigine or Levetiracetam + high-dose Folic acid (4 mg/d). Bipolar: Atypical antipsychotics (Quetiapine, Lurasidone) or fetal echocardiogram if Lithium must be continued |
| Hyperthyroidism (Graves Disease) | Methimazole (in 1st Trimester) & Radioactive Iodine (131I — ALL trimesters) | Methimazole (1st trimester): Aplasia cutis congenita (scalp defect), choanal/esophageal atresia. 131I: Complete ablation of fetal thyroid → congenital cretinism | 1st Trimester: Propylthiouracil (PTU) → Switch to Methimazole in 2nd & 3rd Trimesters (to avoid maternal PTU fulminant hepatotoxicity!) |
| Dermatology / Autoimmune | Isotretinoin (Vitamin A derivatives), Methotrexate, Mycophenolate, Thalidomide | Isotretinoin: Neural crest defect (microtia/anotia, thymic aplasia, conotruncal cardiac defects). Methotrexate: Craniofacial/limb defects, fetal demise. Thalidomide: Phocomelia (seal-like limb reduction) | Acne in pregnancy: Topical Azelaic acid, Erythromycin, or Clindamycin. SLE / Lupus nephritis in pregnancy: Hydroxychloroquine, Prednisone, Azathioprine |
| Antibiotics in Pregnancy | Tetracyclines (Doxycycline), Aminoglycosides (Gentamicin/Streptomycin), Fluoroquinolones, Sulfonamides (3rd trimester) | Tetracyclines: Yellow-brown discoloration of deciduous teeth & inhibition of long-bone growth. Aminoglycosides: CN VIII sensorineural deafness. Fluoroquinolones: Cartilage damage. Sulfonamides (near term): Displace bilirubin from albumin → Kernicterus | Penicillins (Amoxicillin), Cephalosporins (Cephalexin, Ceftriaxone), Azithromycin, or Clindamycin |
Fetal Alcohol Syndrome vs. Maternal Cocaine & Tobacco Effects
Substance exposures produce distinct neonatal phenotypes on board exams: (1) Alcohol is the leading preventable cause of congenital intellectual disability in the United States; Fetal Alcohol Syndrome presents with microcephaly, holoprosencephaly, VSD/ASD, and the classic facial triad of short palpebral fissures, a smooth (hypoplastic) philtrum, and a thin upper vermilion border. (2) Cocaine inhibits monoamine reuptake, triggering intense uterine artery vasoconstriction that causes placental abruption, preterm delivery, intrauterine growth restriction (IUGR), and fetal cerebral infarction/intestinal atresia. (3) Tobacco (Nicotine/CO) impairs uteroplacental perfusion, causing symmetric/asymmetric low birth weight, preterm premature rupture of membranes (PPROM), placenta previa, placental abruption, and Sudden Infant Death Syndrome (SIDS).
Diethylstilbestrol (DES) & Maternal Pregestational Diabetes Teratogenesis
Two non-infectious endocrine/hormonal teratogens carry pathognomonic board associations: (1) In utero exposure to Diethylstilbestrol (DES) (a synthetic nonsteroidal estrogen historically given to prevent miscarriage) causes vaginal adenosis, a T-shaped hypoplastic uterus (predisposing to cervical insufficiency and preterm labor), and clear cell adenocarcinoma of the vagina and cervix in young female offspring. (2) Poorly controlled maternal Pregestational Diabetes Mellitus during first-trimester organogenesis causes caudal regression syndrome (sacral agenesis), transposition of the great arteries, and neural tube defects, while third-trimester fetal hyperinsulinemia causes macrosomia (shoulder dystocia), neonatal hypoglycemia, polycythemia, hypocalcemia, and RDS (insulin inhibits surfactant synthesis).
Organogenesis Vulnerability Window Reference
Reviewing the embryonic organogenesis timeline confirms why preconception counseling—converting a patient from lisinopril to labetalol, warfarin to enoxaparin, or valproate to levetiracetam plus 4 mg folic acid before conception—is essential, as neural tube closure and cardiac septation occur between weeks 3 and 8 post-conception, often before a patient realizes she is pregnant.
Labor Curve Abnormalities (Friedman / Zhang Criteria) & Postpartum Fever Differential
Modern obstetric management of the First Stage of Labor (onset of regular contractions to full 10 cm cervical dilation) reflects the contemporary Consortium on Safe Labor (Zhang) guidelines: the slower Latent Phase extends from 0 to 5 cm dilation, while the rapid Active Phase of Labor officially begins at 6 cm cervical dilation. A prolonged latent phase (>20 hours in nulliparas, >14 hours in multiparas) is NEVER an indication for Cesarean delivery and is managed with therapeutic rest or oxytocin. Once the cervix reaches ≥6 cm dilation, labor progression is evaluated using an intrauterine pressure catheter (IUPC), where adequate uterine contractions are defined as ≥200 Montevideo Units (MVUs) over a 10-minute window.
| Labor Disorder / Postpartum Complication | Diagnostic Criteria / Postpartum Timeline | Pathophysiology & Risk Factors | First-Line Clinical Management |
|---|---|---|---|
| Protracted Active Phase | Cervix ≥ 6 cm with dilation slower than 1–1.2 cm/hr (nullipara) or 1.5 cm/hr (multipara) | Hypotonic uterine dysfunction (Power), cephalopelvic disproportion (Passenger), or narrow pelvis (Passage) | Assess contraction adequacy: if contractions are inadequate (<200 MVUs), perform amniotomy + IV Oxytocin augmentation |
| Arrest of Active Phase (Stage 1 Arrest) | Cervix ≥ 6 cm + Ruptured Membranes + ZERO cervical change for: • ≥ 4 hours with adequate contractions (≥200 MVUs), OR • ≥ 6 hours with inadequate contractions despite oxytocin | True cephalopelvic disproportion (fetal macrosomia, brow/mentum-posterior malpresentation) or uterine inertia | Cesarean Delivery (do NOT perform C-section for arrest before 6 cm dilation!) |
| Arrest of Descent (Stage 2 Arrest) | Cervix fully dilated (10 cm) with no fetal station descent after pushing for: • ≥ 3 hours in Nulliparas • ≥ 2 hours in Multiparas (Add +1 hour if neuraxial epidural analgesia is present) | Occiput posterior malposition, maternal exhaustion, or midpelvic/outlet contraction | If fetal head is engaged (+2 station or lower) → Operative Vaginal Delivery (Forceps or Vacuum); if high station → Cesarean Delivery |
| Postpartum Endometritis ('Womb') | Postpartum Days 2–3 (48–72 hours); #1 risk factor is unscheduled Cesarean delivery after prolonged labor/ROM | Ascending polymicrobial infection of uterine decidua/myometrium (Bacteroides, Prevotella, GBS, Enterococcus, E. coli, Gardnerella) | Fever (≥38.0°C), tachycardia, midline uterine fundal tenderness, foul-smelling purulent lochia. Rx: IV Clindamycin + Gentamicin (covers anaerobes + GNR; add Ampicillin if Enterococcus suspected) |
| Septic Pelvic Thrombophlebitis | Postpartum Days 5–7+: Persistent spiking 'picket-fence' fevers DESPITE ≥48–72 hours of IV Clindamycin + Gentamicin | Endothelial damage and venous stasis in the ovarian (right > left) or iliac veins with infected thrombus | Patient appears clinically well between fever spikes; pelvic CT/MRI shows ovarian vein thrombosis. Rx: Continue broad-spectrum IV antibiotics + add Therapeutic Anticoagulation (Heparin / LMWH) |
| Lactational Mastitis vs. Breast Abscess | Postpartum Weeks 2–6 in breastfeeding mothers (nipple fissures + milk stasis) | Unilateral bacterial invasion via nipple excoriation: Staphylococcus aureus (#1) | Mastitis: Unilateral firm, erythematous wedge-shaped breast tenderness + fever/myalgias → Oral Dicloxacillin or Cephalexin (or TMP-SMX/Clindamycin if MRSA) + CONTINUE Breastfeeding! Abscess: Fluctuant mass on US → Needle aspiration / I&D + antibiotics + continue pumping/feeding |
Shoulder Dystocia Obstetrical Emergency Protocol (McRoberts Maneuver)
During the second stage of labor, retraction of the delivered fetal head tightly against the maternal perineum ('turtle sign') indicates Shoulder Dystocia—impaction of the fetal anterior shoulder behind the maternal pubic symphysis (risk factors: maternal gestational diabetes, fetal macrosomia >4,500–5,000 g, post-term pregnancy). Because umbilical cord compression causes fetal hypoxic acidosis within minutes, immediately execute the McRoberts maneuver (sharp hyperflexion and abduction of the maternal thighs against the abdomen) combined with Suprapubic Pressure (applied directly over the pubic bone to rotate and dislodge the anterior shoulder). NEVER apply fundal pressure (which further impacts the shoulder and risks uterine rupture and Erb-Duchenne brachial plexus palsy!). Secondary maneuvers include Rubin/Woods corkscrew internal rotation, delivery of the posterior arm, and intentional clavicular fracture or Zavanelli maneuver.
Postpartum Hemorrhage (The 4 Ts) & Uterotonic Contraindications
Postpartum Hemorrhage (PPH) is defined as cumulative blood loss ≥1,000 mL (or any blood loss accompanied by hypovolemic instability) within 24 hours of delivery. Etiologies follow the 4 Ts: (1) Tone — Uterine Atony (80%, #1 cause): boggy, enlarged uterus from overdistension (twins, polyhydramnios, macrosomia), chorioamnionitis, prolonged oxytocin, or halogenated anesthetics; (2) Trauma: cervical/vaginal lacerations (firm contracted uterus with ongoing bright-red bleeding) or Uterine Inversion (smooth round mass protruding through cervix after aggressive cord traction → stop uterotonics, give nitroglycerin/terbutaline to relax uterus, manually replace fundus, then start oxytocin!); (3) Tissue: retained placenta/placenta accreta; (4) Thrombin: DIC from abruption or amniotic fluid embolism. For uterine atony, perform bimanual uterine massage + IV Oxytocin (1st line), followed by second-line uterotonics with strict contraindication awareness: Methylergonovine (CONTRAINDICATED in Hypertension/Preeclampsia!), Carboprost / PGF2α (CONTRAINDICATED in Asthma! causes bronchospasm), and Misoprostol (PGE1) or Tranexamic Acid (TXA).
Postpartum Fever Timeline by Postoperative Day (The 6 Ws)
When evaluating a febrile postpartum or post-Cesarean patient, match the day of fever onset to the classic anatomical source: Day 1 (0–24h): Wind (atelectasis or physiological inflammatory response to labor); Days 2–3: Womb (Postpartum Endometritis — uterine tenderness, foul lochia → IV Clindamycin + Gentamicin) or Water (catheter-associated UTI / pyelonephritis); Days 4–5: Wound (Cesarean incision cellulitis, hematoma, or necrotizing fasciitis); Days 5–7+: Walk (deep vein thrombosis / pulmonary embolism or Septic Pelvic Thrombophlebitis if fever persists despite 72h of endometritis antibiotics); and Weeks 2–6: Breast (breast engorgement on days 3–5 causes low-grade fever <38.5°C with bilateral diffuse fullness, whereas infectious Lactational Mastitis occurs weeks 2–6 with unilateral focal wedge erythema and high fever).
OMM Board Correlate: Obstetric Autonomics, Pelvic Diaphragm Mechanics & Labor Facilitation
Uterine & Cervical Autonomic Innervation: Sympathetic innervation to the uterus and fallopian tubes originates from T10–L2 via the inferior mesenteric and hypogastric plexuses; sympathetic stimulation promotes coordinated fundal contraction and vasoconstriction. Parasympathetic innervation arises from the pelvic splanchnic nerves (S2–S4), which mediate cervical ripening, cervical dilation, and uterine vasodilation. Crucially, visceral pain afferents during the first stage of labor (cervical dilation and lower uterine segment distension) travel alongside sympathetic fibers back to T10–L1, whereas somatic perineal pain during the second stage of labor (fetal descent and vaginal stretching) travels via the pudendal nerve to S2–S4.
Biomechanical Adaptations & Chapman Points: Rising relaxin and progesterone levels increase sacroiliac and pubic symphysis ligamentous laxity, while the gravid uterus shifts the maternal center of gravity anteriorly—inducing increased lumbar lordosis, anterior innominate rotation, sacral base anterior nutation (bilateral sacral flexion), and psoas/piriformis hypertonicity (which can compress the sciatic nerve or obstruct the pelvic outlet). The broad ligament Chapman point lies along the lateral thigh (iliotibial band from greater trochanter to knee), while the uterus point lies at the superior medial aspect of the pubic rami.
OMT Protocol & Contraindications: Gentle sacroiliac myofascial release, pelvic diaphragm release, lumbosacral soft tissue, and sacral rocking facilitate labor progression and reduce back labor pain. OMT (especially lumbosacral HVLA or vigorous sacral stimulation) is CONTRAINDICATED in active preterm labor, placenta previa, placental abruption, undiagnosed vaginal bleeding, and ectopic pregnancy.
- In a pregnant patient presenting before 20 weeks gestation with severe preeclampsia (hypertension, proteinuria), hyperemesis gravidarum, hyperthyroidism, vaginal passage of grape-like vesicles, and a uterine size greater than gestational dates, immediately suspect a Complete Hydatidiform Mole (preeclampsia before 20 weeks is virtually pathognomonic for molar pregnancy!).
- Patients with Group B Streptococcus (GBS) bacteriuria at ANY colony count during the current pregnancy OR a previous infant who developed invasive GBS sepsis automatically receive intrapartum IV Penicillin G prophylaxis during labor and DO NOT need a 36–37 week rectovaginal screening culture.
- In a pregnant patient with a severe penicillin allergy (history of anaphylaxis, angioedema, respiratory distress, or urticaria) requiring intrapartum GBS prophylaxis, administer IV Vancomycin if clindamycin susceptibility testing is unavailable or shows inducible resistance; if there is NO history of severe anaphylaxis, use IV Cefazolin.
- Never perform a digital vaginal examination in a second- or third-trimester pregnant patient presenting with painless bright-red vaginal bleeding until an ultrasound has excluded Placenta Previa; digital palpation of a placenta previa can trigger catastrophic, exsanguinating maternal-fetal hemorrhage.
- During active phase labor (>=6 cm cervical dilation) with ruptured membranes, do not diagnose Arrest of Active Phase Labor (and proceed to Cesarean delivery) unless there has been zero cervical change for at least 4 hours of adequate uterine contractions (>=200 Montevideo units on intrauterine pressure catheter) OR at least 6 hours of inadequate contractions despite oxytocin augmentation.
- In postpartum Lactational Mastitis (unilateral wedge-shaped breast erythema, warmth, fever, myalgias in a breastfeeding mother caused by Staphylococcus aureus), ALWAYS instruct the patient to CONTINUE frequent breastfeeding or pumping from the affected breast alongside oral Dicloxacillin or Cephalexin to promote milk drainage and prevent breast abscess formation.